Sanofi, Regeneron restructure 12-year-old partnership

The existing collaboration relating to Dupixent (dupilumab), which recently reached $633 million in global sales, will remain unchanged following the restructuring
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news